BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3447444)

  • 1. Replacement of excretory kidney function by high-efficiency hemodiafiltration (HDF) with a peptide-permeable membrane.
    Wizemann V; Techert F; Brüning S; Birk HW; Mueller K
    Adv Exp Med Biol; 1987; 223():263-6. PubMed ID: 3447444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 3. Membranes and their removal of uremic toxins.
    Hoenich NA
    Adv Exp Med Biol; 1987; 223():253-62. PubMed ID: 3447443
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternate repetition of short fore- and backfiltrations reduces convective albumin loss.
    Shinzato T; Miwa M; Nakai S; Takai I; Matsumoto Y; Morita H; Miyata T; Maeda K
    Kidney Int; 1996 Aug; 50(2):432-5. PubMed ID: 8840270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uremic Toxins: how can we improve the removal today?].
    Teatini U; Romei Longhena G
    G Ital Nefrol; 2017 Sep; 34(5):89-101. PubMed ID: 28963830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hemodialysis and hemodiafiltration on uremic neuropathy.
    Malberti F; Surian M; Farina M; Vitelli E; Mandolfo S; Guri L; De Petri GC; Castellani A
    Blood Purif; 1991; 9(5-6):285-95. PubMed ID: 1668062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with a new hemodiafiltration (HDF) system.
    Rindi P; Pilone N; Riccò V; Cioni L
    ASAIO Trans; 1988; 34(3):765-8. PubMed ID: 3196595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pump assisted continuous venovenous hemofiltration for treating acute uremia.
    Canaud B; Garred LJ; Christol JP; Aubas S; Béraud JJ; Mion C
    Kidney Int Suppl; 1988 Mar; 24():S154-6. PubMed ID: 3163038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins].
    Wratten ML; Sereni L; Lupotti M; Ghezzi PM; Atti M; Formica M
    G Ital Nefrol; 2004; 21 Suppl 30():S67-70. PubMed ID: 15747308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrafiltration-pump assisted continuous arteriovenous hemofiltration (CAVH).
    Chanard J; Milcent T; Toupance O; Melin JP; Roujouleh H; Lavaud S
    Kidney Int Suppl; 1988 Mar; 24():S157-8. PubMed ID: 3129612
    [No Abstract]   [Full Text] [Related]  

  • 13. Removal of small proteins--the stepchild of dialysis therapy. Protein permeability of different hemofiltration membranes analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
    Birk HW; Wizeman V
    Adv Exp Med Biol; 1987; 223():277-80. PubMed ID: 3447446
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of dialysis membranes on the convective transport of middle molecules.
    De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M
    Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of high permeable membranes in hemodiafiltration in children: an optimal method of purification.
    Fischbach M; Hamel G; Geisert J
    Int J Pediatr Nephrol; 1985; 6(4):251-6. PubMed ID: 4093244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall'.
    Cuoghi A; Caiazzo M; Monari E; Bellei E; Bergamini S; Sereni L; Aucella F; Loschiavo C; Atti M; Tomasi A
    J Biomater Appl; 2015 May; 29(10):1363-71. PubMed ID: 25542733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemofiltration and the middle molecule.
    Henderson LW
    Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
    [No Abstract]   [Full Text] [Related]  

  • 18. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for optimizing dialysis therapy. I. Acute effects of hemodiafiltration with a highly permeable membrane and a large dose of convection and diffusion.
    Wizemann V; Birk HW; Vanholder R; de Smet R; Ringoir S; Bleyl H; Schütterle G
    Blood Purif; 1988; 6(3):145-55. PubMed ID: 3395474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal versus continuous versus intermittent therapies for removal of uremic toxins.
    Clark WR; Henderson LW
    Kidney Int Suppl; 2001 Feb; 78():S298-303. PubMed ID: 11169030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.